(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.10%) $83.65
(-1.16%) $1.619
(0.34%) $2 350.40
(-0.53%) $27.21
(0.33%) $923.55
(0.38%) $0.935
(0.77%) $11.04
(0.15%) $0.800
(-0.27%) $91.92
4 days till quarter result
(bmo 2024-04-30)
Expected move: +/- 4.51%
Live Chart Being Loaded With Signals
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific...
Stats | |
---|---|
Today's Volume | 768 520 |
Average Volume | 1.39M |
Market Cap | 24.92B |
EPS | $0 ( 2024-02-08 ) |
Next earnings date | ( $1.870 ) 2024-04-30 |
Last Dividend | $0.240 ( 2023-09-28 ) |
Next Dividend | $0 ( N/A ) |
P/E | 55.77 |
ATR14 | $0.0650 (0.05%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-01 | Winkler Lori | Buy | 772 | Common Stock |
2024-04-01 | Winkler Lori | Sell | 215 | Common Stock |
2024-04-01 | Winkler Lori | Sell | 772 | Restricted Stock Units |
2024-03-31 | Michelson Michael W | Buy | 207 | Phantom Stock Units |
2024-03-31 | Hilado Maria Teresa | Buy | 207 | Phantom Stock Units |
INSIDER POWER |
---|
10.07 |
Last 99 transactions |
Buy: 197 885 | Sell: 163 900 |
Volume Correlation
Zimmer Biomet Holdings Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Zimmer Biomet Holdings Correlation - Currency/Commodity
Zimmer Biomet Holdings Financials
Annual | 2023 |
Revenue: | $7.39B |
Gross Profit: | $4.66B (63.06 %) |
EPS: | $4.91 |
FY | 2023 |
Revenue: | $7.39B |
Gross Profit: | $4.66B (63.06 %) |
EPS: | $4.91 |
FY | 2022 |
Revenue: | $6.94B |
Gross Profit: | $4.92B (70.90 %) |
EPS: | $1.390 |
FY | 2021 |
Revenue: | $7.84B |
Gross Profit: | $5.50B (70.13 %) |
EPS: | $1.930 |
Financial Reports:
No articles found.
Zimmer Biomet Holdings Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.240 (N/A) |
$0.240 (N/A) |
$0.240 (N/A) |
$0.480 (N/A) |
$0.240 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.175 | 2012-03-28 |
Last Dividend | $0.240 | 2023-09-28 |
Next Dividend | $0 | N/A |
Payout Date | 2023-10-31 | |
Next Payout Date | N/A | |
# dividends | 48 | -- |
Total Paid Out | $10.70 | -- |
Avg. Dividend % Per Year | 0.48% | -- |
Score | 4.3 | -- |
Div. Sustainability Score | 9.49 | |
Div.Growth Potential Score | 4.69 | |
Div. Directional Score | 7.09 | -- |
Year | Amount | Yield |
---|---|---|
2012 | $0.700 | 1.34% |
2013 | $0.776 | 1.18% |
2014 | $0.856 | 0.96% |
2015 | $0.856 | 0.78% |
2016 | $0.932 | 0.94% |
2017 | $0.932 | 0.93% |
2018 | $0.932 | 0.77% |
2019 | $0.932 | 0.94% |
2020 | $0.932 | 0.64% |
2021 | $0.932 | 0.63% |
2022 | $0.960 | 0.77% |
2023 | $0.960 | 0.75% |
2024 | $0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
LOMA | Dividend Knight | 2023-06-30 | Quarterly | 2 | 5.23% | 8.53 |
KIO | Dividend Royal | 2023-12-14 | Monthly | 12 | 7.05% | 8.50 |
NCZ | Dividend Royal | 2024-02-09 | Monthly | 22 | 7.79% | 8.50 |
SCM | Dividend King | 2023-12-15 | Monthly | 13 | 7.08% | 8.50 |
SJT | Dividend Royal | 2023-11-29 | Monthly | 39 | 12.52% | 8.50 |
SRV | Dividend Royal | 2023-12-04 | Monthly | 18 | 7.53% | 8.50 |
VGI | Dividend Royal | 2024-02-09 | Monthly | 13 | 7.36% | 8.50 |
JQC | Dividend Royal | 2023-11-14 | Monthly | 22 | 6.56% | 8.50 |
PHK | Dividend Royal | 2023-11-10 | Monthly | 22 | 6.88% | 8.50 |
PCF | Dividend King | 2023-12-18 | Monthly | 38 | 7.05% | 8.50 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.138 | 1.500 | 7.23 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0476 | 1.200 | 8.41 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0827 | 1.500 | -0.192 | -0.289 | [0.1 - 1] |
payoutRatioTTM | 0.196 | -1.000 | 8.04 | -8.04 | [0 - 1] |
currentRatioTTM | 1.613 | 0.800 | 6.93 | 5.55 | [1 - 3] |
quickRatioTTM | 0.650 | 0.800 | -0.881 | -0.704 | [0.8 - 2.5] |
cashRatioTTM | 0.146 | 1.500 | -0.303 | -0.454 | [0.2 - 2] |
debtRatioTTM | 0.271 | -1.500 | 5.49 | -8.23 | [0 - 0.6] |
interestCoverageTTM | 6.75 | 1.000 | 8.61 | 8.61 | [3 - 30] |
operatingCashFlowPerShareTTM | 7.58 | 2.00 | 7.47 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 5.39 | 2.00 | 7.30 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.466 | -1.500 | 8.13 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.718 | 1.000 | 1.363 | 1.363 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.184 | 1.000 | 8.33 | 8.33 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.272 | 1.000 | 9.60 | 9.60 | [0.2 - 2] |
assetTurnoverTTM | 0.344 | 0.800 | -1.040 | -0.832 | [0.5 - 2] |
Total Score | 9.49 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 24.39 | 1.000 | 7.64 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0827 | 2.50 | -0.124 | -0.289 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 5.39 | 2.00 | 8.20 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.601 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 7.58 | 2.00 | 7.47 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.196 | 1.500 | 8.04 | -8.04 | [0 - 1] |
pegRatioTTM | -0.260 | 1.500 | -5.07 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.214 | 1.000 | 7.15 | 0 | [0.1 - 0.5] |
Total Score | 4.69 |
Zimmer Biomet Holdings
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest toss facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as robotic, surgical and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators